Detalhe da pesquisa
1.
ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype.
Int J Mol Sci
; 22(20)2021 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34681953
2.
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.
Theranostics
; 13(6): 1876-1891, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064866
3.
Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.
Mol Ther Oncolytics
; 30: 153-166, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674627
4.
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
Biosci Rep
; 41(9)2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519332
5.
PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Commun Biol
; 4(1): 923, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326464
6.
Immunostimulating and Gram-negative-specific antibacterial cyclotides from the butterfly pea (Clitoria ternatea).
FEBS J
; 283(11): 2067-90, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27007913
7.
Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Commun Biol
; 4(1): 1282, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750497
8.
The fetal mouse metatarsal bone explant as a model of angiogenesis.
Nat Protoc
; 10(10): 1459-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26334866